Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Troost

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Kidney International Reports|August 24, 2019
Text Messaging for Disease Monitoring in Childhood Nephrotic SyndromeChia-Shi Wang, Jonathan P Troost, Larry A Greenbaum, et al.
Kidney International Reports|October 26, 2020
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN StudyShannon L Murphy, John D Mahan, Jonathan P Troost, et al.
Kidney International Reports|December 18, 2019
Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)Michelle M O'Shaughnessy, Jonathan P Troost, Andrew S Bomback, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2020
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Tocilizumab for treatment of mechanically ventilated patients with COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.
Pediatric Nephrology (Berlin, Germany)|March 19, 2015
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyDavid T Selewski, Jonathan P Troost, Susan F Massengill, et al.
Health and Quality of Life Outcomes|August 25, 2017
Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium studyDavid T Selewski, Jonathan P Troost, Danyelle Cummings, et al.
Kidney International Reports|May 5, 2018
NephCure Accelerating Cures Institute: A Multidisciplinary Consortium to Improve Care for Nephrotic SyndromeDebbie S Gipson, David T Selewski, Susan F Massengill, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2015
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE SubjectsMatthew G Sampson, Catherine C Robertson, Sebastian Martini, et al.
Kidney International Reports|April 14, 2020
Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic SyndromeDebbie S Gipson, Howard Trachtman, Anne Waldo, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Kidney International Reports|August 24, 2019
Text Messaging for Disease Monitoring in Childhood Nephrotic SyndromeChia-Shi Wang, Jonathan P Troost, Larry A Greenbaum, et al.
Kidney International Reports|October 26, 2020
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN StudyShannon L Murphy, John D Mahan, Jonathan P Troost, et al.
Kidney International Reports|December 18, 2019
Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)Michelle M O'Shaughnessy, Jonathan P Troost, Andrew S Bomback, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2020
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Tocilizumab for treatment of mechanically ventilated patients with COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.
Pediatric Nephrology (Berlin, Germany)|March 19, 2015
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyDavid T Selewski, Jonathan P Troost, Susan F Massengill, et al.
Health and Quality of Life Outcomes|August 25, 2017
Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium studyDavid T Selewski, Jonathan P Troost, Danyelle Cummings, et al.
Kidney International Reports|May 5, 2018
NephCure Accelerating Cures Institute: A Multidisciplinary Consortium to Improve Care for Nephrotic SyndromeDebbie S Gipson, David T Selewski, Susan F Massengill, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2015
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE SubjectsMatthew G Sampson, Catherine C Robertson, Sebastian Martini, et al.
Kidney International Reports|April 14, 2020
Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic SyndromeDebbie S Gipson, Howard Trachtman, Anne Waldo, et al.
Pageof 13